Compare APAM & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APAM | ICUI |
|---|---|---|
| Founded | 1994 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.2B |
| IPO Year | 2013 | 1992 |
| Metric | APAM | ICUI |
|---|---|---|
| Price | $41.49 | $147.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | $47.00 | ★ $183.60 |
| AVG Volume (30 Days) | ★ 468.3K | 238.1K |
| Earning Date | 10-28-2025 | 11-06-2025 |
| Dividend Yield | ★ 8.75% | N/A |
| EPS Growth | ★ 2.95 | N/A |
| EPS | ★ 3.71 | N/A |
| Revenue | $1,158,234,000.00 | ★ $2,320,363,000.00 |
| Revenue This Year | $8.38 | N/A |
| Revenue Next Year | $6.56 | N/A |
| P/E Ratio | $11.19 | ★ N/A |
| Revenue Growth | ★ 8.88 | N/A |
| 52 Week Low | $32.75 | $107.00 |
| 52 Week High | $48.50 | $175.51 |
| Indicator | APAM | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 44.36 | 63.17 |
| Support Level | $39.94 | $141.10 |
| Resistance Level | $43.06 | $148.95 |
| Average True Range (ATR) | 0.90 | 4.68 |
| MACD | 0.05 | -0.41 |
| Stochastic Oscillator | 51.36 | 64.92 |
Artisan Partners Asset Management Inc is a investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. In addition to its equity strategies, customers may invest in a fixed-income strategy. Strategies are often distributed to customers ranging from retail investors to institutional investors through specialized channels.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.